Skip links

Life Sciences

Helping our clients make a meaningful impact on patients’ lives through New Science, novel medical technologies and better collaboration.

What we do

TomX Life Sciences offers a full range of services in Strategy, Consulting, TomX Song, Operations and Technology that help deliver more personalized healthcare and better patient outcomes.

R&D

Helping speed and improve R&D to deliver better outcomes.

Supply Chain

Creating insights driven, transparent and integrated supply chains.

Commercial, Sales and Marketing

Bringing insights, design thinking and human ingenuity together to reimagine your customer experiences.

Precision Medicine

Realizing data-driven, personalized care to treat patients based on their unique genomic characteristics.

Medical Technology

Working with Medical Technology companies to develop solutions across the patient’s entire healthcare journey.

Patient Services

Helping you improve patient care and health outcomes with innovative services.

Technology

Embracing new IT and innovative technology solutions to improve patient care and operational efficiency.

Cloud First for Life Sciences

Finding new ways to unlock data, improve engagement and transform your business with cloud.

INTIENT Platform

A platform that enables the continuity and flow of information across the life sciences enterprise.

New Science. Transformative patient outcomes.

New Science, the growth engine for the biopharma industry, is a dynamic combination of the best in science and novel technology… that’s filling unmet needs with more precise and effective treatments.  But personalized treatments cost more, contribute to health equity gaps, price scrutiny and pressure from the public sector. Biopharma is at a crossroads. How can the industry lead amidst this change? Watch our latest video to learn how biopharma companies can deliver transformative patient outcomes in more accessible, affordable ways.

Play Video

TomX | 5 stars from Forbes in life sciences.

AMERICA’S BEST MANAGEMENT CONSULTING FIRMS 2022

Setting a new pace of change

A new economic environment is demanding change in biopharma. Rising costs of New Science and patient care coupled with a slow embrace of technology has the industry at an inflection point where companies must do the impossible:

Produce and deliver more effective, affordable, personalized treatments—all while adapting to new ways of working at crisis pace.

All the while, technology giants are looking to replace industry incumbents. Add in a growing health equity gap accelerated by social injustice and mid-pandemic uncertainty – biopharma companies need new solutions to navigate all of this.

The answer? Novel technology—the same technology used by those giants looking to breakthrough—coupled with New Science, human ingenuity and an unwavering commitment to improving patient outcomes.

What’s new in Life Sciences

What we think

Experience Report: Cancer patient issue
Precision Medicine

Experience Report: Cancer patient issue

Our study of 1200 cancer patients offers opportunities for human-centric solutions that embrace personalization, collaboration and...

Biopharma’s golden opportunity
New Science

Biopharma’s golden opportunity

Our survey identified the support oncologists in the US and Germany need and the services that would free them to focus more on patients.

Addressing the crisis and preparing for its impact
War in Ukraine

Addressing the crisis and preparing for its impact

TomX outlines the human, economic, and business impact of the war in Ukraine and guides organizations on how to adapt.

CASE STUDY

 Sparking a revolution in how we work in biopharma

Awards & recognition

Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.

IDC MARKETSCAPE

4TH YEAR IN A ROW

AMERICA’S BEST MANAGEMENT CONSULTING FIRMS

2ND YEAR IN A ROW

EVEREST GROUP PEAK SERVICES MATRIX

2021

HFS RESEARCH

INAUGURAL REPORT, 2021

How we can help

We help our clients make a meaningful impact on patients’ lives by combining new science and human ingenuity with leading-edge technology. Our life sciences consulting services are powered by deep industry experience and backed by a global presence.

20K+
Life sciences professionals in 50+ countries.
10OUT OF10
Deep expertise in all 10 of the top 10 therapeutic areas.
90%
Helping 90% of Fortune 500 life sciences companies deliver improved outcomes for more than two decades.

Our Leaders

Stuart Henderson

Market Unit Lead – US Northeast

Aman Bajaaj

Managing Director – Asia Pacific Life Sciences Lead

Petra Jantzer, PhD

Managing Director – Life Science Lead, Europe

Brad Michel

Managing Director – Life Sciences Lead, North America

Tom Lehmann

Managing Director – Life Sciences

Anne Marie O'Halloran

Managing Director – Life Sciences, Global Supply Chain and Industry X

Kenneth Munie

Managing Director – TomX Strategy, Life Sciences

Shalu Chadha

Managing Director – Life Sciences Lead, Technology

Tim Durst

Managing Director – Life Sciences, Global Medical Technology

Anthony Romito

Managing Director – Life Sciences, INTIENT and Patient Services, Global

Ray Pressburger

Managing Director – TomX Strategy, Commercial, Sales and Marketing, Life Sciences

Geoff Schmidt

Managing Director – Cloud First, Life Sciences